Lunan Pharmaceutical
FDA Approved Drugs

Lunan Pharmaceutical

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified RX
  • Total Records 27
  • Latest Approval Date Jul 13, 2026
  • Data Source FDA
  • First Approval Date May 07, 2019
All
27
View
Unclassified
5
View
RX
22
View
Company Overview

Company

Lunan Pharmaceutical

Country

China

Website

Visit Website

Email

Ibo@lunan.com.cn

Social Profiles

Company Snapshot

Lunan Pharmaceutical

No. 209, Hongqi Road, Linyi City, Shandong Province, 276006

China

www.lunanpharma.com/ Ibo@lunan.com.cn View on Map
FDA Approved Drug Records ( 27 records )
-
Unclassified Application: 219583

Drug Name

BRIVARACETAM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

219583 / 1

Active Ingredient

BRIVARACETAM

Application Number

219583

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219583

Drug Name

BRIVARACETAM

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

219583 / 2

Active Ingredient

BRIVARACETAM

Application Number

219583

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219583

Drug Name

BRIVARACETAM

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

219583 / 3

Active Ingredient

BRIVARACETAM

Application Number

219583

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219583

Drug Name

BRIVARACETAM

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

-

219583 / 4

Active Ingredient

BRIVARACETAM

Application Number

219583

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219583

Drug Name

BRIVARACETAM

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

-

219583 / 5

Active Ingredient

BRIVARACETAM

Application Number

219583

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

2026
13 Jul
RX Application: 219766

Drug Name

BRIVARACETAM

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2026-07-13

219766 / 1

Active Ingredient

BRIVARACETAM

Application Number

219766

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2026-07-13

Regulatory Status

RX

2025
04 Nov
RX Application: 216527

Drug Name

ISOFLURANE

Product Number

1

Dosage Form

-

Strength

99.9%

Approval Date

2025-11-04

216527 / 1

Active Ingredient

ISOFLURANE

Application Number

216527

Product Number

1

Dosage Form

-

Strength

99.9%

Approval Date

2025-11-04

Regulatory Status

RX

2022
29 Apr
RX Application: 214115

Drug Name

ISOSORBIDE MONONITRATE

Product Number

1

Dosage Form

-

Strength

120MG

Approval Date

2022-04-29

214115 / 1

Active Ingredient

ISOSORBIDE MONONITRATE

Application Number

214115

Product Number

1

Dosage Form

-

Strength

120MG

Approval Date

2022-04-29

Regulatory Status

RX

2024
08 Feb
RX Application: 214115

Drug Name

ISOSORBIDE MONONITRATE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2024-02-08

214115 / 2

Active Ingredient

ISOSORBIDE MONONITRATE

Application Number

214115

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2024-02-08

Regulatory Status

RX

2024
08 Feb
RX Application: 214115

Drug Name

ISOSORBIDE MONONITRATE

Product Number

3

Dosage Form

-

Strength

60MG

Approval Date

2024-02-08

214115 / 3

Active Ingredient

ISOSORBIDE MONONITRATE

Application Number

214115

Product Number

3

Dosage Form

-

Strength

60MG

Approval Date

2024-02-08

Regulatory Status

RX

2023
23 Jan
RX Application: 216373

Drug Name

MILRINONE LACTATE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML

Approval Date

2023-01-23

216373 / 1

Active Ingredient

MILRINONE LACTATE

Application Number

216373

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML

Approval Date

2023-01-23

Regulatory Status

RX

2025
09 Jul
RX Application: 217274

Drug Name

OSELTAMIVIR PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2025-07-09

217274 / 1

Active Ingredient

OSELTAMIVIR PHOSPHATE

Application Number

217274

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2025-07-09

Regulatory Status

RX

2025
09 Jul
RX Application: 217274

Drug Name

OSELTAMIVIR PHOSPHATE

Product Number

2

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2025-07-09

217274 / 2

Active Ingredient

OSELTAMIVIR PHOSPHATE

Application Number

217274

Product Number

2

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2025-07-09

Regulatory Status

RX

2025
09 Jul
RX Application: 217274

Drug Name

OSELTAMIVIR PHOSPHATE

Product Number

3

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2025-07-09

217274 / 3

Active Ingredient

OSELTAMIVIR PHOSPHATE

Application Number

217274

Product Number

3

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2025-07-09

Regulatory Status

RX

2026
15 Jan
RX Application: 219765

Drug Name

OXALIPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/10ML (5MG/ML)

Approval Date

2026-01-15

219765 / 1

Active Ingredient

OXALIPLATIN

Application Number

219765

Product Number

1

Dosage Form

-

Strength

50MG/10ML (5MG/ML)

Approval Date

2026-01-15

Regulatory Status

RX

2026
15 Jan
RX Application: 219765

Drug Name

OXALIPLATIN

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2026-01-15

219765 / 2

Active Ingredient

OXALIPLATIN

Application Number

219765

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2026-01-15

Regulatory Status

RX

2024
12 Jul
RX Application: 215684

Drug Name

ROCURONIUM BROMIDE

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2024-07-12

215684 / 1

Active Ingredient

ROCURONIUM BROMIDE

Application Number

215684

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2024-07-12

Regulatory Status

RX

2024
12 Jul
RX Application: 215684

Drug Name

ROCURONIUM BROMIDE

Product Number

2

Dosage Form

-

Strength

100MG/10ML (10MG/ML)

Approval Date

2024-07-12

215684 / 2

Active Ingredient

ROCURONIUM BROMIDE

Application Number

215684

Product Number

2

Dosage Form

-

Strength

100MG/10ML (10MG/ML)

Approval Date

2024-07-12

Regulatory Status

RX

2019
07 May
RX Application: 207375

Drug Name

ROSUVASTATIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2019-05-07

207375 / 1

Active Ingredient

ROSUVASTATIN CALCIUM

Application Number

207375

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2019-05-07

Regulatory Status

RX

2019
07 May
RX Application: 207375

Drug Name

ROSUVASTATIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2019-05-07

207375 / 2

Active Ingredient

ROSUVASTATIN CALCIUM

Application Number

207375

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2019-05-07

Regulatory Status

RX

2019
07 May
RX Application: 207375

Drug Name

ROSUVASTATIN CALCIUM

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2019-05-07

207375 / 3

Active Ingredient

ROSUVASTATIN CALCIUM

Application Number

207375

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2019-05-07

Regulatory Status

RX

2019
07 May
RX Application: 207375

Drug Name

ROSUVASTATIN CALCIUM

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2019-05-07

207375 / 4

Active Ingredient

ROSUVASTATIN CALCIUM

Application Number

207375

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2019-05-07

Regulatory Status

RX

2023
18 Aug
RX Application: 214382

Drug Name

SEVOFLURANE

Product Number

1

Dosage Form

-

Strength

100%

Approval Date

2023-08-18

214382 / 1

Active Ingredient

SEVOFLURANE

Application Number

214382

Product Number

1

Dosage Form

-

Strength

100%

Approval Date

2023-08-18

Regulatory Status

RX

2024
04 Mar
RX Application: 216279

Drug Name

TADALAFIL

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2024-03-04

216279 / 1

Active Ingredient

TADALAFIL

Application Number

216279

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2024-03-04

Regulatory Status

RX

2024
04 Dec
RX Application: 216279

Drug Name

TADALAFIL

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2024-12-04

216279 / 2

Active Ingredient

TADALAFIL

Application Number

216279

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2024-12-04

Regulatory Status

RX

2024
04 Dec
RX Application: 216279

Drug Name

TADALAFIL

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2024-12-04

216279 / 3

Active Ingredient

TADALAFIL

Application Number

216279

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2024-12-04

Regulatory Status

RX

2024
04 Dec
RX Application: 216279

Drug Name

TADALAFIL

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2024-12-04

216279 / 4

Active Ingredient

TADALAFIL

Application Number

216279

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2024-12-04

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    9 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    27 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
27 total
  • Unclassified
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BRIVARACETAM

Application Number

219583

Product Number

1

Active Ingredient

BRIVARACETAM

Dosage Form

-

Strength

10MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit